NEW YORK ( TheStreet) -- Transcept Pharmaceuticals (Nasdaq: TSPT) hit a new 52-week high Monday as it is currently trading at $11.92, above its previous 52-week high of $11.88 with 407,807 shares traded as of 3 p.m. ET. Average volume has been 382,600 shares over the past 30 days. Transcept has a market cap of $110.7 million and is part of the health care sector and drugs industry. Shares are up 42% year to date as of the close of trading on Thursday. Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter